Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Soria

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
AIDS and Behavior|March 25, 2024
Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections AcquisitionRoberto Rossotti, Alessandro Tavelli, Daniele Calzavara, et al.
Plos One|June 4, 2010
CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individualsAlessandra Bandera, Giulio Ferrario, Marina Saresella, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 22, 2020
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohortsRoberto Rossotti, Alessandro Tavelli, Stefano Bonora, et al.
Journal of Neurovirology|July 9, 2019
Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patientsMassimiliano Fabbiani, Nicoletta Ciccarelli, Valeria Castelli, et al.
Sexually Transmitted Diseases|May 9, 2025
Knowledge, Use, and Misuse of Self-Prescribed Doxycycline Postexposure Prophylaxis in a Community-Based Preexposure Prophylaxis ServiceRoberto Rossotti, Enrico Caruso, Daniele Calzavara, et al.
AIDS Research and Therapy|February 15, 2025
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patientMaria Kogan, Antonio Maria Alviano, Martina Catalano, et al.
The New Microbiologica|November 12, 2014
Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo studyNicola Gianotti, Andrea Poli, Massimo Galli, et al.
HIV Medicine|December 17, 2023
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effectsAlice Ranzani, Francesco Castelli, Antonio Di Biagio, et al.
Antiviral Therapy|May 29, 2009
Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patientsAlessandro Soria, Klaudia Porten, Jean-Calvin Fampou-Toundji, et al.
Open Forum Infectious Diseases|November 18, 2020
Remdesivir Use in Patients Requiring Mechanical Ventilation due to COVID-19Giuseppe Lapadula, Davide Paolo Bernasconi, Giacomo Bellani, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
AIDS and Behavior|March 25, 2024
Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections AcquisitionRoberto Rossotti, Alessandro Tavelli, Daniele Calzavara, et al.
Plos One|June 4, 2010
CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individualsAlessandra Bandera, Giulio Ferrario, Marina Saresella, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 22, 2020
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohortsRoberto Rossotti, Alessandro Tavelli, Stefano Bonora, et al.
Journal of Neurovirology|July 9, 2019
Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patientsMassimiliano Fabbiani, Nicoletta Ciccarelli, Valeria Castelli, et al.
Sexually Transmitted Diseases|May 9, 2025
Knowledge, Use, and Misuse of Self-Prescribed Doxycycline Postexposure Prophylaxis in a Community-Based Preexposure Prophylaxis ServiceRoberto Rossotti, Enrico Caruso, Daniele Calzavara, et al.
AIDS Research and Therapy|February 15, 2025
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patientMaria Kogan, Antonio Maria Alviano, Martina Catalano, et al.
The New Microbiologica|November 12, 2014
Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo studyNicola Gianotti, Andrea Poli, Massimo Galli, et al.
HIV Medicine|December 17, 2023
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effectsAlice Ranzani, Francesco Castelli, Antonio Di Biagio, et al.
Antiviral Therapy|May 29, 2009
Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patientsAlessandro Soria, Klaudia Porten, Jean-Calvin Fampou-Toundji, et al.
Open Forum Infectious Diseases|November 18, 2020
Remdesivir Use in Patients Requiring Mechanical Ventilation due to COVID-19Giuseppe Lapadula, Davide Paolo Bernasconi, Giacomo Bellani, et al.
Pageof 6